Literature DB >> 2618

Arylsulfatase B of human lung. Isolation, characterization, and interaction with slow-reacting substance of anaphylaxis.

S I Wasserman, K F Austen.   

Abstract

Arylsulfatase B was separated from arylsulfatase A in extracts of human lung tissue by anion exchange chromatography and further purified by gel filtration and cation exchange chromatography. Arylsulfatase B of human lung was similar to that enzyme in other tissues and species, exhibiting an apparent mol wt of approximately 60,000, a pH optimum for cleavage of 4-nitrocatechol sulfate (pNCS) of 5.5-6.0, and a sensitivity to inhibition by phosphate ions and especially pyrophosphate in the presence of NaCl. Human lung arylsulfatase B inactivated slow-reacting substance of anaphylaxix (SRS-A) in a linear time-dependent reaction in which the rate was determined by the enzyme-to-substrate ratio. Cleavage of pNCS by human lung arylsulfatase B was competitively suppressed by SRS-A. The finding that human lung tissue contains predominately arylsulfatase B discloses a potential regulatory mechanism for inactivation of SRS-A at or near the site of its generation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 2618      PMCID: PMC436709          DOI: 10.1172/JCI108332

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Arylsulfatase activity in beef and rabbit corneal extracts.

Authors:  B WORTMAN
Journal:  Arch Biochem Biophys       Date:  1962-04       Impact factor: 4.013

2.  The assay of arylsulphatases A and B in human urine.

Authors:  H BAUM; K S DODGSON; B SPENCER
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

3.  The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.

Authors:  W E BROCKLEHURST
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

4.  Studies on sulphatases. 12. The arylsulphatases of human tissues.

Authors:  K S DODGSON; B SPENCER; C H WYNN
Journal:  Biochem J       Date:  1956-03       Impact factor: 3.857

5.  The sulphatase of ox liver. I. The complex nature of the enzyme.

Authors:  A B ROY
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

6.  Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.

Authors:  R P Orange; W G Austen; K F Austen
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

7.  The type II arylsulphatases of the red kangaroo.

Authors:  A B Roy
Journal:  Biochim Biophys Acta       Date:  1971-01-13

8.  The sulfatase of ox liver. X. Some observations on the intermolecular bonding in sulfatase A.

Authors:  L W Nichol; A B Roy
Journal:  Biochemistry       Date:  1966-04       Impact factor: 3.162

9.  Purification and properties of arylsulfatase. A from human urine.

Authors:  R L Stevens; A L Fluharty; M H Skokut; H Kihara
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

10.  Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis.

Authors:  E J Goetzl; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

View more
  10 in total

Review 1.  Biology of the mast cell and its role in cutaneous inflammation.

Authors:  B U Wintroub; N A Soter
Journal:  Springer Semin Immunopathol       Date:  1981-06

2.  On the preparation of highly purified slow reacting substance of anaphylaxis (SRS-A) from biological extracts.

Authors:  G J Blackwell; J F Burka; R J Flower; P Torkington
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

3.  Mast cell-mediated reactions of host defense and tissue injury: the regulatory role of eosinophil polymorphonuclear leukocytes.

Authors:  E J Goetzl
Journal:  Inflammation       Date:  1977-09       Impact factor: 4.092

4.  Expression and Distribution of Arylsulfatase B are Closely Associated with Neuron Death in SOD1 G93A Transgenic Mice.

Authors:  Jie Zhang; Huiting Liang; Lei Zhu; Weiming Gan; Chunyan Tang; Jiao Li; Renshi Xu
Journal:  Mol Neurobiol       Date:  2017-01-26       Impact factor: 5.590

5.  Differential effects of a partially purified preparation of slow-reacting substance of anaphylaxis on guinea pig tracheal spirals and parenchymal strips.

Authors:  J M Drazen; R A Lewis; S I Wasserman; R P Orange; K F Austen
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

6.  Human eosinophil arylsulfatase B. Structure and activity of the purified tetrameric lysosomal hydrolase.

Authors:  P F Weller; K F Austen
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

7.  Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice.

Authors:  Matthew L Renninger; Rosemarie E Seymour; Laurence O Whiteley; John P Sundberg; Harm Hogenesch
Journal:  Exp Dermatol       Date:  2009-07-23       Impact factor: 3.960

8.  Human platelet arylsulphatases: identification and capacity to destroy SRS-A.

Authors:  D D Metcalfe; L M Corash; M Kaliner
Journal:  Immunology       Date:  1979-08       Impact factor: 7.397

9.  Identification of the slow reacting substances from cat paws.

Authors:  J Houglum; J K Pai; V Atrache; D E Sok; C J Sih
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Arylsulfatase B improves locomotor function after mouse spinal cord injury.

Authors:  Myungsik Yoo; Muntasir Khaled; Kurt M Gibbs; Jonghun Kim; Björn Kowalewski; Thomas Dierks; Melitta Schachner
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.